{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:20:00Z","timestamp":1794608400849,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["R01HL148112 01"],"award-info":[{"award-number":["R01HL148112 01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88938-w","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:23:15Z","timestamp":1739186595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation"],"prefix":"10.1038","volume":"15","author":[{"given":"David","family":"Polhemus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Almodiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymios","family":"Ziogos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Amat-Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Santhanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gerstenblith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten M.","family":"Leucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"88938_CR1","doi-asserted-by":"crossref","unstructured":"Gliozzi, M. et al. Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development. Int. J. Mol. Sci. 20 (13). (2019).","DOI":"10.3390\/ijms20133294"},{"issue":"10","key":"88938_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.cdd.4400581","volume":"6","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler, S. & Zeiher, A. M. Nitric oxide-an endothelial cell survival factor. Cell. Death Differ. 6 (10), 964\u2013968 (1999).","journal-title":"Cell. Death Differ."},{"issue":"22","key":"88938_CR3","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.2174\/13816128113196660748","volume":"20","author":"S Karbach","year":"2014","unstructured":"Karbach, S., Wenzel, P., Waisman, A., Munzel, T. & Daiber, A. eNOS uncoupling in cardiovascular diseases - the role of oxidative stress and inflammation. Curr. Pharm. Des. 20(22), 3579\u20133594. https:\/\/doi.org\/10.2174\/13816128113196660748 (2014).","journal-title":"Curr. Pharm. Des."},{"issue":"20","key":"88938_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","volume":"123","author":"JP Stasch","year":"2011","unstructured":"Stasch, J. P., Pacher, P. & Evgenov, O. V. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123 (20), 2263\u20132273 (2011).","journal-title":"Circulation"},{"issue":"9","key":"88938_CR5","first-page":"1039","volume":"11","author":"J Tamargo","year":"2010","unstructured":"Tamargo, J. et al. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure. Curr. Opin. Investig Drugs 11 (9), 1039\u20131047 (2010).","journal-title":"Curr. Opin. Investig Drugs"},{"issue":"3","key":"88938_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00210-012-0730-6","volume":"385","author":"J Schlossmann","year":"2012","unstructured":"Schlossmann, J. & Schinner, E. cGMP becomes a drug target. Naunyn Schmiedebergs Arch. Pharmacol. 385 (3), 243\u2013252 (2012).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2","key":"88938_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0021-9150(99)00333-0","volume":"149","author":"J Sinisalo","year":"2000","unstructured":"Sinisalo, J. et al. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 149 (2), 403\u2013411 (2000).","journal-title":"Atherosclerosis"},{"issue":"3","key":"88938_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11357-012-9402-1","volume":"35","author":"AJ Wadley","year":"2013","unstructured":"Wadley, A. J., Veldhuijzen, J. J., van Zanten & Aldred, S. The interactions of oxidative stress and inflammation with vascular dysfunction in ageing: the vascular health triad. Age (Dordr) 35 (3), 705\u2013718 (2013).","journal-title":"Age (Dordr)"},{"key":"88938_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/164_2018_197","volume":"264","author":"P Sandner","year":"2021","unstructured":"Sandner, P. et al. Soluble Guanylate Cyclase stimulators and activators. Handb. Exp. Pharmacol. 264, 355\u2013394 (2021).","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"88938_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/ATVBAHA.109.199893","volume":"30","author":"NO Rizzo","year":"2010","unstructured":"Rizzo, N. O. et al. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler. Thromb. Vasc Biol. 30 (4), 758\u2013765 (2010).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"1","key":"88938_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/cvr\/cvp388","volume":"86","author":"JH Xue","year":"2010","unstructured":"Xue, J. H. et al. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc. Res. 86 (1), 141\u2013150 (2010).","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"88938_CR12","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/s41467-020-18980-x","volume":"11","author":"MJ Ranek","year":"2020","unstructured":"Ranek, M. J. et al. CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury. Nat. Commun. 11 (1), 5237 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"88938_CR13","doi-asserted-by":"publisher","first-page":"H49","DOI":"10.1152\/ajpheart.00670.2018","volume":"317","author":"J Steppan","year":"2019","unstructured":"Steppan, J. et al. Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening. Am. J. Physiol. Heart Circ. Physiol. 317 (1), H49\u2013H59 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"88938_CR14","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1073\/pnas.0511154103","volume":"103","author":"T Yu","year":"2006","unstructured":"Yu, T., Robotham, J. L. & Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. U S A 103 (8), 2653\u20132658 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"88938_CR15","first-page":"23","volume":"5","author":"E Awad","year":"2022","unstructured":"Awad, E. et al. Role of apoptosis and oxidative stress in high glucose-induced endothelial dysfunction in isolated aortic rings. J. Adv. Biomed. Pharm. Sci. 5 (1), 23\u201328 (2022).","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"issue":"5","key":"88938_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1172\/JCI115179","volume":"87","author":"B Tesfamariam","year":"1991","unstructured":"Tesfamariam, B., Brown, M. L. & Cohen, R. A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87 (5), 1643\u20131648 (1991).","journal-title":"J. Clin. Invest."},{"issue":"6865","key":"88938_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (6865), 813\u2013820 (2001).","journal-title":"Nature"},{"issue":"2","key":"88938_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","volume":"36","author":"AR Cyr","year":"2020","unstructured":"Cyr, A. R. et al. Nitric oxide and endothelial dysfunction. Crit. Care Clin. 36 (2), 307\u2013321 (2020).","journal-title":"Crit. Care Clin."},{"issue":"5","key":"88938_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/01.ATV.14.5.753","volume":"14","author":"AJ Cayatte","year":"1994","unstructured":"Cayatte, A. J. et al. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14 (5), 753\u2013759 (1994).","journal-title":"Arterioscler. Thromb."},{"issue":"5","key":"88938_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/01.ATV.14.5.746","volume":"14","author":"K Naruse","year":"1994","unstructured":"Naruse, K. et al. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler. Thromb. 14 (5), 746\u2013752 (1994).","journal-title":"Arterioscler. Thromb."},{"issue":"3","key":"88938_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/01.CIR.95.3.553","volume":"95","author":"AM Lefer","year":"1997","unstructured":"Lefer, A. M. Nitric oxide: nature\u2019s naturally occurring leukocyte inhibitor. Circulation 95 (3), 553\u2013554 (1997).","journal-title":"Circulation"},{"issue":"2","key":"88938_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0033-0620(05)80001-5","volume":"38","author":"J Loscalzo","year":"1995","unstructured":"Loscalzo, J. & Welch, G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc. Dis. 38 (2), 87\u2013104 (1995).","journal-title":"Prog Cardiovasc. Dis."},{"issue":"3","key":"88938_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/15230860050192161","volume":"2","author":"FS Laroux","year":"2000","unstructured":"Laroux, F. S. et al. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid. Redox Signal. 2 (3), 391\u2013396 (2000).","journal-title":"Antioxid. Redox Signal."},{"issue":"47","key":"88938_CR24","doi-asserted-by":"publisher","first-page":"16671","DOI":"10.1073\/pnas.0405509101","volume":"101","author":"VO Melichar","year":"2004","unstructured":"Melichar, V. O. et al. Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 101 (47), 16671\u201316676 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"24","key":"88938_CR25","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","volume":"84","author":"LJ Ignarro","year":"1987","unstructured":"Ignarro, L. J. et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U S A 84 (24), 9265\u20139269 (1987).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"88938_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","volume":"151","author":"MR Miller","year":"2007","unstructured":"Miller, M. R. & Megson, I. L. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 151 (3), 305\u2013321 (2007).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"88938_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/hh0102.102330","volume":"90","author":"LJ Ignarro","year":"2002","unstructured":"Ignarro, L. J., Napoli, C. & Loscalzo, J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 90 (1), 21\u201328 (2002).","journal-title":"Circ. Res."},{"issue":"20","key":"88938_CR28","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong, P. W. et al. Vericiguat in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 382(20), 1883-1893. https:\/\/doi.org\/10.1056\/NEJMoa1915928 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"88938_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-023-05935-5","volume":"14","author":"Z Bahadoran","year":"2023","unstructured":"Bahadoran, Z. et al. Vascular nitric oxide resistance in type 2 diabetes. Cell. Death Dis. 14 (7), 410 (2023).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"88938_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong, P. et al. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal. Transduct. Target. Ther. 7 (1), 131 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"88938_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.ATV.0000125114.88079.96","volume":"24","author":"S Kawashima","year":"2004","unstructured":"Kawashima, S. & Yokoyama, M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler. Thromb. Vasc Biol. 24 (6), 998\u20131005 (2004).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"1","key":"88938_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/09629359791875","volume":"6","author":"KE Matthys","year":"1997","unstructured":"Matthys, K. E. & Bult, H. Nitric oxide function in atherosclerosis. Mediators Inflamm. 6 (1), 3\u201321 (1997).","journal-title":"Mediators Inflamm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88938-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88938-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88938-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:23:19Z","timestamp":1739186599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88938-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88938"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88938-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4939"}}